Timeline: 
* 07/05/2021: Nature communication: [gemcitabine and cabazitaxel](https://www.nature.com/articles/s41467-019-09917-0) for acute myeloid leukemia (AML)
* 02/28/2020: drug repurposing: pheWAS, methylation, expression, proteinomics
